Dylan is the Founder & CEO of Mindbloom.co, a NYC-based mental health and wellbeing startup helping people expand their human potential with clinician-prescribed, guided psychedelic medicine experiences. There, he is partnering with clinicians, technologists, researchers, and patients to increase access to science-backed treatments, starting by reducing the cost of ketamine therapy for depression and anxiety by over 65%. Dylan is a 10-year psychedelic medicine patient and 3-time tech entrepreneur with both $100M+ in funding and an exit in his prior startups, which were focused on increasing access to justice and democracy. Dylan graduated from The Wharton School at The University of Pennsylvania.

NOTE: The Zur Institute is having a 10% off sale on all their Continuing Education courses.  I have over 100 units of CE- worthy interviews there.  Check it out and splurge on some by going to:  http://www.zurinstitute.com/dvannuys.html